MedTrace Logo

A 56-day Clinical Study on Facial Skin Rejuvenation

NCT06188338 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-08-16

No results posted yet for this study

Summary

This clinical trial aims to learn about the efficacy of MLYAAT-1002® (a proprietary anti-aging complex, MLYAAT is short for "multi-layer anti-ageing technology" ) in female subjects who have newly received the rejuvenation treatment by comparing visual clinical scores, skin attributes measurement and image analysis.

Conditions

  • Skin Manifestations
  • Wrinkle
  • Photoaging

Interventions

COMBINATION_PRODUCT

Fractional picosecond laser treatment followed by daily use of formulations containing MLYAAT-1002®.

Each subject will receive a single treatment of the fractional picosecond laser, followed by the first application of the active comparator on the randomly assigned side of the split-face (the treatment side) on the same day, and sequently, will apply the active comparator to this side twice a day for 56 days.

COMBINATION_PRODUCT

Fractional picosecond laser treatment followed by daily use of formulations without MLYAAT-1002®

Each subject will receive a single treatment of the fractional picosecond laser, followed by the first application of the placebo comparator on the randomly assigned side of the split-face (the control side) on the same day, and sequently, will apply the placebo comparator to this side twice a day for 56 days.

Sponsors & Collaborators

  • Botanee Group Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Yan Shuxian, Dr · Shanghai Yaokang Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-18
Primary Completion
2024-01-27
Completion
2024-08-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06188338 on ClinicalTrials.gov